5 Results for "

C2C12 cell line

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "C2C12 cell line" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-112820
CAS No.: 500008-45-7
Purity:  98.06%
Research Areas:  

Others

Chlorantraniliprole is an insecticide that potently and selectively activates insect ryanodine receptor, with EC50s of 40 nM and 50 nM for Drosophila melanogaster and H. virescens ryanodine receptor, and ~300-fold more potent than that in the mouse myoblast cell line, C2C12 (EC50, 14 μM).
loading...
    loading...
Cat. No.: HY-150795
CAS No.: 2603461-70-5
Purity:  99.54%
Target:  

TGF-beta/Smad PI3K Akt ERK JNK

Research Areas:  

Others

SY-LB-35 is a potent bone morphogenetic protein (BMP) receptor agonist. SY-LB-35 can stimulate significant increases in cell number and cell viability in the C2C12 myoblast cell line, and causes shifts towards the S and G2/M phases of the cell cycle. SY-LB-35 stimulates canonical Smad and non-canonical PI3K/Akt, ERK, p38 and JNK intracellular signaling pathways .
loading...
    loading...
Cat. No.: HY-112820R
CAS No.: 500008-45-7
Research Areas:  

Others

Chlorantraniliprole (Standard) is the analytical standard of Chlorantraniliprole. This product is intended for research and analytical applications. Chlorantraniliprole is an insecticide that potently and selectively activates insect ryanodine receptor, with EC50s of 40 nM and 50 nM for Drosophila melanogaster and H. virescens ryanodine receptor, and ~300-fold more potent than that in the mouse myoblast cell line, C2C12 (EC50, 14 μM).
loading...
    loading...
Cat. No.: HY-W721606
Chlorantraniliprole-d6 is the deuterium labeled Chlorantraniliprole (HY-112820). Chlorantraniliprole is an insecticide that potently and selectively activates insect ryanodine receptor, with EC50s of 40 nM and 50 nM for Drosophila melanogaster and H. virescens ryanodine receptor, and ~300-fold more potent than that in the mouse myoblast cell line, C2C12 (EC50, 14 μM).
loading...
    loading...
Cat. No.: HY-162578
Target:  

PPAR

Research Areas:  

Metabolic Disease

PPARα/γ agonist 4 (Compound (S)-7) is an orally active dual potent agonist of PPARα and PPARγ, with EC50 values of 0.061 μM and 1.42 μM respectively. PPARα/γ agonist 4 acts through an insulin-independent mechanism and exhibits mitochondrial pyruvate carrier inhibition and anti-diabetic properties. PPARα/γ agonist 4 is expected to be used in research for dyslipidemic type 2 diabetes .
loading...
    loading...